Skip to content

Efficacy of intravenous paracetamol to prevent perioperative shivering in patients undergoing transurethral resection of the prostate (TURP)

Efficacy of intravenous paracetamol to prevent perioperative shivering in patients undergoing transurethral resection of the prostate (TURP)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250427005
Enrollment
90
Registered
2025-04-27
Start date
2025-04-21
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing Transurethral Resection of the Prostate (TURP) under spinal anesthesia TURP Shivering Paracetamol Acetaminophen Spinal anesthesia

Interventions

An anesthesiologist not involved in patient care prepared the study drug. The drug will be transferred from its original vial, prepared, and labeled with the patient&#039
s identification number under sterile conditions. The study solution contained 1,000 mg of paracetamol in a 100 mL volume, administered intravenously over a 15-minute drip starting after lithotomy pos
Experimental Drug,Placebo Comparator Drug
1,000 mg of paracetamol,100 mL of normal saline

Sponsors

Faculty of Medicine Ramathibodi Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age > 40 years. (Patients older than 60 years will undergo cognitive function assessment using the Mini-Cog test. Participants without cognitive impairment will provide consent themselves. If cognitive impairment is present, consent will be obtained from a first-degree relative.) 2. ASA Physical status I - III 3. Undergoing Transurethral Resection of the Prostate (TURP) Under Spinal Anesthesia

Exclusion criteria

Exclusion criteria: 1. Decline to provide consent to participate in a study 2. Patient with contraindications for spinal anesthesia 3. All participants that have history of paracetamol allergy and its substance allergy 4. Participants who are at risk for taking paracetamol including severe liver cirrhosis, alcohol abuse, or malnutrition 5. End stage renal disease (ESRD) 6. Severe COPD 7. Body weight less than 50 kilogram 8. Body temperature greater than 37.8 C or less than 36 C

Design outcomes

Primary

MeasureTime frame
incidence of shivering every 10 minutes after spinal anesthesia until the surgery is completed, and then at 0, 15, 30, 45, and 60 minutes in the recovery room. A bedside shivering assessment score of one or more

Secondary

MeasureTime frame
body temperature and vital signs before and after spinal anesthesia every 10 minutes until the surgery is completed, and then at 0, 15, 30, 45, and 60 minutes in the recovery room. Blood pressure, heart rate, body temperature, oxygen saturation,The bedside shivering assessment score after spinal anesthesia every 10 minutes until the surgery is completed, followed by recordings at 0, 15, 30, 45, and 60 minutes in the recovery room. 0 is no shivering, 1 is piloerection or vasoconstriction without visible shivering, 2 is one muscle group, 3 is multiple groups, and 4 is whole-body shivering.,Pain scores 0, 15, 30, 45, and 60 minutes in the recovery room Numeric Rating Scale,Total opioid consumption from the time after spinal anesthesia up to 24 hours postoperatively. morphine equivalent (mg),complications from the time after spinal anesthesia up to 24 hours postoperatively. such as hypotension, nausea, or vomiting

Countries

Thailand

Contacts

Public ContactSasima Dusitkasem

Department of Anesthesiology Faculty of Medicine Ramathibodi Hospital, Mahidol University

sasima1308@gmail.com0814229151

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026